Cerevel Therapeutics Holdings Inc (NAS:CERE)
$ 42.3 0.24 (0.57%) Market Cap: 7.71 Bil Enterprise Value: 7.03 Bil PE Ratio: 0 PB Ratio: 13.55 GF Score: 40/100

Q2 2023 Cerevel Therapeutics Holdings Inc Earnings Call Transcript

Aug 02, 2023 / 12:00PM GMT
Release Date Price: $26.33 (-14.09%)
Operator

Good morning, and welcome to the Cerevel Therapeutics Second Quarter Financial Results Conference Call. At this time, all participants are in listen-only mode. Later, you will have the opportunity to ask questions during the Q&A portion of the call. Please note that this call may be recorded. I will now hand the call over to Matthew Calistri, Vice President of Investor Relations.

Matthew Calistri
Cerevel Therapeutics Holdings, Inc. - VP of IR

Thank you. Good morning, everyone. We appreciate you joining us for our second quarter 2023 earnings call. On today's call, you'll be hearing from Ronald Renaud, our President and Chief Executive Officer; Dr. Ray Sanchez, our Chief Medical Officer; Dr. John Renger, our Chief Scientific Officer; and Dr. Susan Altschuller, our Chief Financial Officer. During our call today, please refer to our Press Release from this morning detailing our second quarter 2023 financial performance as well as our updated Corporate Presentation, both of which are available on our website.

I would like to remind you that we will be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot